Ebola vaccine development plan: ethics, concerns and proposed measures
Open Access
- 8 February 2016
- journal article
- research article
- Published by Springer Nature in BMC Medical Ethics
- Vol. 17 (1) , 10
Abstract
The global interest in developing therapies for Ebola infection management and its prevention is laudable. However the plan to conduct an emergency immunization program specifically for healthcare workers using experimental vaccines raises some ethical concerns. This paper shares perspectives on these concerns and suggests how some of them may best be addressed. The recruitment of healthcare workers for Ebola vaccine research has challenges. It could result in coercion of initially dissenting healthcare workers to assist in the management of EVD infected persons due to mistaken beliefs that the vaccine offers protection. It could also affect equity and justice. For example, where people who are not skilled health care professionals but who provide care to patients infected with Ebola (such as in home care settings) are not prioritized for vaccination. The possibility of study participants contracting Ebola infection despite the use of experimental vaccine, and the standard of care they would receive, needs to be addressed clearly, transparently and formalized as part of the ethics review process. Future access to study products in view of current status of the TRIPS agreement needs to be addressed. Finally, broad stakeholder engagement at local, regional and international levels needs to be promoted using available communication channels to engage local, regional and international support. These same concerns are applicable for current and future epidemics. Successful Ebola vaccine development research requires concerted efforts at public dialogue to address misconceptions, equity and justice in participant selection, and honest discussions about risks, benefits and future access. Public dialogue about Ebola vaccine research plans is crucial and should be conducted by trusted locals and negotiated between communities, researchers and ethics committees in research study sites.Keywords
This publication has 48 references indexed in Scilit:
- Engaging Diverse Social and Cultural Worlds: Perspectives on Benefits in International Clinical Research From South African CommunitiesDeveloping World Bioethics, 2013
- Willingness to Participate in HIV Vaccine Trials among Men Who Have Sex with Men in Chennai and Mumbai, India: A Social Ecological ApproachPLOS ONE, 2012
- Hepatitis B: Epidemiology and prevention in developing countriesWorld Journal of Hepatology, 2012
- A Qualitative Analysis of Vaccine Safety Perceptions and Concerns Among Caretakers in UgandaMaternal and Child Health Journal, 2011
- How ethical is your clinical trial?International Journal Of Clinical Practice, 2010
- Ethics and the ethnography of medical research in AfricaSocial Science & Medicine, 2008
- Autism and Measles-Mumps-Rubella VaccinationCNS Drugs, 2001
- ‘It's terminal either way’: an analysis of armed conflict in liberia, 1989–1996Review of African Political Economy, 1997
- Ironies of post‐cold war structural adjustment in Sierra LeoneReview of African Political Economy, 1996
- Equipoise and the Ethics of Clinical ResearchNew England Journal of Medicine, 1987